References
- Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-753. https://doi.org/10.1016/j.pan.2017.07.007
- Basturk O, Hong SM, Wood LD, et al. A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015;39:1730-1741. https://doi.org/10.1097/PAS.0000000000000533
- Miyasaka Y, Ohtsuka T, Tamura K, et al. Predictive factors for the metachronous development of high-risk lesions in the remnant pancreas after partial pancreatectomy for intraductal papillary mucinous neoplasm. Ann Surg 2016;263:1180-1187. https://doi.org/10.1097/SLA.0000000000001368
- Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011;60:1712-1720. https://doi.org/10.1136/gut.2010.232272
- Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg 2011;253:968-974. https://doi.org/10.1097/SLA.0b013e318214bcb4
- Hirono S, Shimizu Y, Ohtsuka T, et al. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol 2020;55:86-99. https://doi.org/10.1007/s00535-019-01617-2
- Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788-797; discussion 797-799. https://doi.org/10.1097/01.sla.0000128306.90650.aa
- Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 2011;60:509-516. https://doi.org/10.1136/gut.2010.210567
- European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789-804. https://doi.org/10.1136/gutjnl-2018-316027
- Vege SS, Ziring B, Jain R, Moayyedi P; Clinical Guidelines Committee; American Gastroenterology Association. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015;148:819-822; quize812-813. https://doi.org/10.1053/j.gastro.2015.01.015
- Oyama H, Tada M, Takagi K, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology 2020;158:226-237.e225. https://doi.org/10.1053/j.gastro.2019.08.032
- Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-651; discussion 651-654. https://doi.org/10.1097/SLA.0b013e318155a9e5
- Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-79; quiz 309-310. https://doi.org/10.1053/j.gastro.2007.05.010
- Waters JA, Schmidt CM, Pinchot JW, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12:101-109. https://doi.org/10.1007/s11605-007-0367-9
- Mori Y, Ohtsuka T, Kono H, et al. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012;41:1008-1012. https://doi.org/10.1097/MPA.0b013e31824b22c6
- Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012;255:326-333. https://doi.org/10.1097/SLA.0b013e3182378a18
- Shi C, Klein AP, Goggins M, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res 2009;15:7737-7743. https://doi.org/10.1158/1078-0432.CCR-09-0004
- Bartsch DK, Dietzel K, Bargello M, et al. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? Fam Cancer 2013;12:89-96. https://doi.org/10.1007/s10689-012-9582-y
- Skaro M, Nanda N, Gauthier C, et al. Prevalence of germline mutations associated with cancer risk in patients with intraductal papillary mucinous neoplasms. Gastroenterology 2019;156:1905-1913. https://doi.org/10.1053/j.gastro.2019.01.254
- He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg 2013;216:657-665; discussion 665-667. https://doi.org/10.1016/j.jamcollsurg.2012.12.026
- Kang CM, Choi SH, Kim SC, Lee WJ, Choi DW, Kim SW. Predicting recurrence of pancreatic solid pseudopapillary tumors after surgical resection: a multicenter analysis in Korea. Ann Surg 2014;260:348-355. https://doi.org/10.1097/sla.0000000000000583
- Dhar VK, Merchant NB, Patel SH, et al. Does surgical margin impact recurrence in noninvasive intraductal papillary mucinous neoplasms?: a multi-institutional study. Ann Surg 2018;268:469-478. https://doi.org/10.1097/SLA.0000000000002923
- Marchegiani G, Mino-Kenudson M, Sahora K, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg 2015;261:976-983. https://doi.org/10.1097/SLA.0000000000000813
- Tamura K, Ohtsuka T, Ideno N, et al. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 2014;259:360-368. https://doi.org/10.1097/SLA.0b013e3182a690ff
- Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatos-copy and intraductal ultrasonography. Gastroenterology 2002;122:34-43. https://doi.org/10.1053/gast.2002.30337
- Nagayoshi Y, Aso T, Ohtsuka T, et al. Peroral pancreatoscopy using the SpyGlass system for the assessment of intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 2014;21:410-417. https://doi.org/10.1002/jhbp.44
- Ohtsuka T, Gotoh Y, Nakashima Y, et al. Role of Spy-Glass-DSTM in the preoperative assessment of pancreatic intraductal papillary mucinous neoplasm involving the main pancreatic duct. Pancreatology 2018;18:566-571. https://doi.org/10.1016/j.pan.2018.04.012
- Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 2008;143:639-646; discussion 646. https://doi.org/10.1001/archsurg.143.7.639
- Miller JR, Meyer JE, Waters JA, et al. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB (Oxford) 2011;13:759-766. https://doi.org/10.1111/j.1477-2574.2011.00354.x
- Moriya T, Traverso W. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study. Arch Surg 2012;147:528-534.
- Frankel TL, LaFemina J, Bamboat ZM, et al. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. HPB (Oxford) 2013;15:814-821. https://doi.org/10.1111/hpb.12137
- Pea A, Yu J, Rezaee N, et al. Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg 2017;266:133-141. https://doi.org/10.1097/SLA.0000000000001817
- Hirono S, Kawai M, Okada K, et al. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery 2016;160:306-317. https://doi.org/10.1016/j.surg.2016.04.007
- Rezaee N, Barbon C, Zaki A, et al. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford) 2016;18:236-246. https://doi.org/10.1016/j.hpb.2015.10.010
- Al Efishat M, Attiyeh MA, Eaton AA, et al. Progression patterns in the remnant pancreas after resection of noninvasive or micro-invasive intraductal papillary mucinous neoplasms (IPMN). Ann Surg Oncol 2018;25:1752-1759. https://doi.org/10.1245/s10434-018-6445-2
- Date K, Ohtsuka T, Fujimoto T, et al. Molecular evidence for monoclonal skip progression in main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2017;265:969-977. https://doi.org/10.1097/SLA.0000000000001755
- Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010;251:70-75. https://doi.org/10.1097/SLA.0b013e3181c5ddc3
- Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011;40:571-580. https://doi.org/10.1097/MPA.0b013e318215010c
- Ideno N, Ohtsuka T, Kono H, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013;258:141-151. https://doi.org/10.1097/sla.0b013e31828cd008
- Kobayashi G, Fujita N, Maguchi H, et al. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas 2014;43:532-538. https://doi.org/10.1097/MPA.0000000000000080
- Matsuda R, Miyasaka Y, Ohishi Y, et al. Concomitant intraductal papillary mucinous neoplasm in pancreatic ductal adenocarcinoma is an independent predictive factor for the occurrence of new cancer in the remnant pancreas. Ann Surg 2020;271:941-948. https://doi.org/10.1097/SLA.0000000000003060
- Ohtsuka T, Tanaka M. Postoperative surveillance of main duct IPMN. In: Tanaka M, ed. Intraductal papillary mucinous neoplasm of the pancreas. Tokyo: Springer, 2014:181-188.
- Ohtsuka T, Tanaka M. Postoperative surveillance of branch duct IPMN. In: Tanaka M, ed. Intraductal papillary mucinous neoplasm of the pancreas. Tokyo: Springer, 2014:189-199.